AAN.com
Quick search in Citations
AnywhereCitation
Advanced Search
Trending Terms:
Brief Communications
June 26, 2006

Response of cluster headache to psilocybin and LSD

R. Andrew Sewell, MD, John H. Halpern, MD, and Harrison G. Pope, Jr, MDAuthors Info & Affiliations
June 27, 2006 issue
66 (12) 1920-1922
https://doi.org/10.1212/01.wnl.0000219761.05466.43
Letters to the Editor
Track CitationsAdd to favorites
Get Access

Abstract

The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition. Twenty-two of 26 psilocybin users reported that psilocybin aborted attacks; 25 of 48 psilocybin users and 7 of 8 LSD users reported cluster period termination; 18 of 19 psilocybin users and 4 of 5 LSD users reported remission period extension. Research on the effects of psilocybin and LSD on cluster headache may be warranted.

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

Supplementary Material

File (e1.doc)

References

1.
Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgia 2000;20:787–803.
PubMed
Google Scholar
2.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004;24 (suppl 1):44–48.
Crossref
PubMed
Google Scholar
3.
Ekbom K. Some remarks on the terminology of cluster headache. Cephalalgia 1988;8:59–60.
PubMed
Google Scholar
4.
Etter JF, Perneger TV. A comparison of cigarette smokers recruited through the Internet or by mail. Int J Epidemiol 2001;30:521–525.
Crossref
PubMed
Google Scholar
5.
Leone M, D'Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000;54:1382–1385.
Crossref
PubMed
Google Scholar
6.
Marks DR, Rapoport A, Padla D, et al. A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia 1993;13:114–116.
Crossref
PubMed
Google Scholar
7.
Leone M, D'Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996;16:494–496.
Crossref
PubMed
Google Scholar
8.
van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003;60:630–633.
Crossref
PubMed
Google Scholar

Information & Authors

Information

Published In

Neurology®
Volume 66 • Number 12 • June 27, 2006
Pages: 1920-1922
PubMed: 16801660

Copyright

© 2006.

Publication History

Published online: June 26, 2006
Published in print: June 27, 2006

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

R. Andrew Sewell, MD
From the Biological Psychiatry Laboratory (J.H.H., H.G.P.) and Clinical Research Laboratory (R.A.S.), Alcohol and Drug Abuse Research Center, McLean Hospital/Harvard Medical School, Belmont, MA.
View all articles by this author
John H. Halpern, MD
From the Biological Psychiatry Laboratory (J.H.H., H.G.P.) and Clinical Research Laboratory (R.A.S.), Alcohol and Drug Abuse Research Center, McLean Hospital/Harvard Medical School, Belmont, MA.
View all articles by this author
Harrison G. Pope, Jr, MD
From the Biological Psychiatry Laboratory (J.H.H., H.G.P.) and Clinical Research Laboratory (R.A.S.), Alcohol and Drug Abuse Research Center, McLean Hospital/Harvard Medical School, Belmont, MA.
View all articles by this author

Notes

Address correspondence and reprint requests to Dr. R. Andrew Sewell, Oaks Building, ADARC, McLean Hospital, 115 Mill St., Belmont, MA 02478; e-mail: [email protected].

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
    • Alireza Mohammad Hosseini,
    • Hossein Khaleghzadeh‐Ahangar,
    • Atena Rahimi,
    The immunomodulatory effects of psychedelics in Alzheimer’s disease-related dementia, Neuroscience, 564, (271-280), (2025).https://doi.org/10.1016/j.neuroscience.2024.11.062
    Crossref
    • Victor S. Wang,
    • Stephen D. Silberstein,
    Ergots, Migraine Pain Management, (243-255), (2025).https://doi.org/10.1016/B978-0-443-24705-7.00015-6
    Crossref
    • Stephen B. Shrewsbury,
    • Alec Mian,
    • Timothy Houle,
    • Stephen Donoghue,
    • Emmanuelle Schindler,
    • Markus A. Dahlem,
    Challenges and controversies; pharmacokinetics, linguistics, semantics and statistics, Migraine Pain Management, (93-117), (2025).https://doi.org/10.1016/B978-0-443-24705-7.00006-5
    Crossref
    • Bushra Yasin,
    • Shivani Mehta,
    • George Tewfik,
    • Alex Bekker,
    Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives, Exploration of Neuroscience, 3, 5, (418-433), (2024).https://doi.org/10.37349/en.2024.00058
    Crossref
    • Gabriella Smedfors,
    • Felicia Jennysdotter Olofsgård,
    • Anna Steinberg,
    • Elisabet Waldenlind,
    • Caroline Ran,
    • Andrea Carmine Belin,
    Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort, Brain Sciences, 14, 4, (348), (2024).https://doi.org/10.3390/brainsci14040348
    Crossref
    • Julia Bornemann,
    • James B. Close,
    • Kirran Ahmad,
    • Tommaso Barba,
    • Kate Godfrey,
    • Lauren Macdonald,
    • David Erritzoe,
    • David Nutt,
    • Robin Carhart-Harris,
    Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”, Frontiers in Psychiatry, 15, (2024).https://doi.org/10.3389/fpsyt.2024.1320780
    Crossref
    • Jan Thomann,
    • Karolina E. Kolaczynska,
    • Oliver V. Stoeckmann,
    • Deborah Rudin,
    • Patrick Vizeli,
    • Marius C. Hoener,
    • Christopher R. Pryce,
    • Franz X. Vollenweider,
    • Matthias E. Liechti,
    • Urs Duthaler,
    In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin, Frontiers in Pharmacology, 15, (2024).https://doi.org/10.3389/fphar.2024.1391689
    Crossref
    • Christopher Robinson,
    • Alexandra Fonseca,
    • Efemena Diejomaoh,
    • Ryan D'Souza,
    • Michael Schatman,
    • Vwaire Orhurhu,
    • Trent Emerick,
    Scoping Review: The Role of Psychedelics in the Management of Chronic Pain, Journal of Pain Research, Volume 17, (965-973), (2024).https://doi.org/10.2147/JPR.S439348
    Crossref
    • James Rucker,
    • Matt Butler,
    • Sadie Hambleton,
    • Catherine Bird,
    • Mathieu Seynaeve,
    • Sanjay Cheema,
    • Kete Campbell‐Coker,
    • Carolina Maggio,
    • Fiona Dunbar,
    • Giorgio Lambru,
    • Manjit Matharu,
    Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study, Headache: The Journal of Head and Face Pain, 64, 10, (1309-1317), (2024).https://doi.org/10.1111/head.14837
    Crossref
    • Martin K. Madsen,
    • Anja Sofie Petersen,
    • Dea S. Stenbæk,
    • Inger Marie Sørensen,
    • Harald Schiønning,
    • Tobias Fjeld,
    • Charlotte H. Nykjær,
    • Sara Marie Ulv Larsen,
    • Maria Grzywacz,
    • Tobias Mathiesen,
    • Ida L. Klausen,
    • Oliver Overgaard‐Hansen,
    • Kristoffer Brendstrup‐Brix,
    • Kristian Linnet,
    • Sys S. Johansen,
    • Patrick M. Fisher,
    • Rigmor H. Jensen,
    • Gitte M. Knudsen,
    CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity , Headache: The Journal of Head and Face Pain, 64, 1, (55-67), (2024).https://doi.org/10.1111/head.14656
    Crossref
  11. See more

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share

View full text|Download PDF